Literature DB >> 23361909

Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice.

Fatemehsadat Esteghamat1, Nynke Gillemans, Ivan Bilic, Emile van den Akker, Ileana Cantù, Teus van Gent, Ursula Klingmüller, Kirsten van Lom, Marieke von Lindern, Frank Grosveld, Thamar Bryn van Dijk, Meinrad Busslinger, Sjaak Philipsen.   

Abstract

B-cell lymphoma 11A (BCL11A) downregulation in human primary adult erythroid progenitors results in elevated expression of fetal γ-globin. Recent reports showed that BCL11A expression is activated by KLF1, leading to γ-globin repression. To study regulation of erythropoiesis and globin expression by KLF1 and BCL11A in an in vivo model, we used mice carrying a human β-globin locus transgene with combinations of Klf1 knockout, Bcl11a floxed, and EpoR(Cre) knockin alleles. We found a higher percentage of reticulocytes in adult Klf1(wt/ko) mice and a mild compensated anemia in Bcl11a(cko/cko) mice. These phenotypes were more pronounced in compound Klf1(wt/ko)::Bcl11a(cko/cko) mice. Analysis of Klf1(wt/ko), Bcl11a(cko/cko), and Klf1(wt/ko)::Bcl11a(cko/cko) mutant embryos demonstrated increased expression of mouse embryonic globins during fetal development. Expression of human γ-globin remained high in Bcl11a(cko/cko) embryos during fetal development, and this was further augmented in Klf1(wt/ko)::Bcl11a(cko/cko) embryos. After birth, expression of human γ-globin and mouse embryonic globins decreased in Bcl11a(cko/cko) and Klf1(wt/ko)::Bcl11a(cko/cko) mice, but the levels remained much higher than those observed in control animals. Collectively, our data support an important role for the KLF1-BCL11A axis in erythroid maturation and developmental regulation of globin expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23361909     DOI: 10.1182/blood-2012-06-434530

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny.

Authors:  Kai-Hsin Chang; Andy Huang; Hemei Han; Yi Jiang; Xiangdong Fang; Chao-Zhong Song; Steve Padilla; Hao Wang; Hongzhu Qu; John Stamatoyannopoulos; Qiliang Li; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2013-08-28       Impact factor: 3.084

Review 2.  Concise review: stem cell-based approaches to red blood cell production for transfusion.

Authors:  Siddharth Shah; Xiaosong Huang; Linzhao Cheng
Journal:  Stem Cells Transl Med       Date:  2013-12-20       Impact factor: 6.940

3.  An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.

Authors:  Daniel E Bauer; Sophia C Kamran; Samuel Lessard; Jian Xu; Yuko Fujiwara; Carrie Lin; Zhen Shao; Matthew C Canver; Elenoe C Smith; Luca Pinello; Peter J Sabo; Jeff Vierstra; Richard A Voit; Guo-Cheng Yuan; Matthew H Porteus; John A Stamatoyannopoulos; Guillaume Lettre; Stuart H Orkin
Journal:  Science       Date:  2013-10-11       Impact factor: 47.728

Review 4.  Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment.

Authors:  Gibran Ali; Muhammad Akram Tariq; Kamran Shahid; Fridoon Jawad Ahmad; Javed Akram
Journal:  Gene Ther       Date:  2020-04-30       Impact factor: 5.250

Review 5.  Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.

Authors:  Daniel E Bauer; Stuart H Orkin
Journal:  Curr Opin Genet Dev       Date:  2015-09-14       Impact factor: 5.578

Review 6.  Molecular basis of β thalassemia and potential therapeutic targets.

Authors:  Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2017-06-20       Impact factor: 3.039

7.  GATA3 Abundance Is a Critical Determinant of T Cell Receptor β Allelic Exclusion.

Authors:  Chia-Jui Ku; JoAnn M Sekiguchi; Bharat Panwar; Yuanfang Guan; Satoru Takahashi; Keigyou Yoh; Ivan Maillard; Tomonori Hosoya; James Douglas Engel
Journal:  Mol Cell Biol       Date:  2017-05-31       Impact factor: 4.272

Review 8.  Erythroid development in the mammalian embryo.

Authors:  Margaret H Baron; Andrei Vacaru; Johnathan Nieves
Journal:  Blood Cells Mol Dis       Date:  2013-08-07       Impact factor: 3.039

Review 9.  An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference.

Authors:  Gerd A Blobel; David Bodine; Marjorie Brand; John Crispino; Marella F T R de Bruijn; David Nathan; Thalia Papayannopoulou; Catherine Porcher; John Strouboulis; Len Zon; Douglas R Higgs; George Stamatoyannopoulos; James Douglas Engel
Journal:  Exp Hematol       Date:  2015-07-02       Impact factor: 3.084

10.  Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL.

Authors:  Kongtana Trakarnsanga; Marieangela C Wilson; Winnie Lau; Belinda K Singleton; Steve F Parsons; Punthita Sakuntanaga; Ryo Kurita; Yukio Nakamura; David J Anstee; Jan Frayne
Journal:  Haematologica       Date:  2014-08-08       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.